Revenue of segments of the OTC pharmaceuticals market in Asia 2022

Concerning the five selected segments, the segment Cold & Cough Remedies has the largest revenue with 14,427,597,921.8 U.S. dollars. Contrastingly, Skin Treatment is ranked last, with 6,965,329,736.26 U.S. dollars. Their difference, compared to Cold & Cough Remedies, lies at 7,462,268,185.54 U.S. dollars.

Find other insights concerning similar markets and segments, such as a ranking by country regarding revenue in the OTC pharmaceuticals market and a ranking by country regarding revenue in the OTC pharmaceuticals market.

The Statista Market Insights cover a broad range of additional markets.

Revenue of segments of the OTC pharmaceuticals market in Asia in 2022

Characteristic	Total revenue
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

More information

Supplementary notes

Data provided by Statista Market Insights are estimates.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Citation formats